Cancer Vaccines
Geron Receives Milestone Payment From Exeter Life Sciences
Published in Vaccine Weekly, April 30th, 2008
Geron Corporation (Nasdaq:GERN) announced that is has received a milestone payment of $1.5 million from Exeter Life Sciences, Inc. as a result of the final Risk Assessment released by the U.S. Food and Drug Administration addressing food products made from cloned animals or their progeny. The Risk Assessment, available at http://www.fda.gov/cvm/CloneRiskAssessment_Final.htm, concluded that consumption of such food products poses no greater risk than consumption of food products from animals produced by conventional breeding methods.
In April 2005, Geron and Exeter Life Sciences created a joint venture company, Start Licensing, Inc., ("Start") to manage and license a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-04-30)
More Articles from Vaccine Weekly
- Flu Vaccines
Flu vaccines can reduce respiratory problems by up to 75 percent - Flu Vaccines
Scientists discover the travel patterns of seasonal flu - Asthma
Study results from K.L. Mcdonald and colleagues broaden understanding of asthma - Autism
UMDF Statement on the Connection Between Mitochondrial Disease and Autism - Bird Flu
Study findings from University of Michigan broaden understanding of bird flu - Chickenpox
New findings from Kaiser Permanente in the area of chickenpox described - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
